A potential adverse role for leptin and cardiac leptin receptor in the right ventricle in pulmonary arterial hypertension: effect of metformin is BMPR2 mutation-specific is a research paper published in Frontiers in Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: P01 HL108800
NIH HHS
Grant: S10 OD018015
NHLBI NIH HHS
Grant: K08 HL153956
NHLBI NIH HHS
Grant: R01 HL122417
NHLBI NIH HHS
Grant: R01 HL146588
BLRD VA
Grant: IK2 BX005828
NHLBI NIH HHS
Grant: K08 HL121174
FDA HHS
Grant: R01 FD007627
NHLBI NIH HHS
Grant: R01 HL155278
National Institutes of Health
Grant: 5IK2BX005828-03
A Pathogenic Role for the Natriuretic Peptide Clearance Receptor in Heart Failure with Preserved Ejection Fraction.
National Institutes of Health
Grant: 1K08HL153956-01A1
A Pathogenic Role for Natriuretic Peptide Receptor-C in Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction
National Institutes of Health
Grant: 5R01HL122417-06
Lipid Deposition in the Right Ventricle in Pulmonary Arterial Hypertension
National Institutes of Health
Grant: 5R01HL155278-04
Clinical and Mechanistic Understanding of Right Ventricular Steatosis in Pulmonary Arterial Hypertension
National Institutes of Health
Grant: 3R01HL146588-01S1
Clinical, Genetic, and Proteomic Risk Factors for Pulmonary Hypertension in Heart Failure
National Institutes of Health
Grant: 6K08HL121174-03
Metabolic Reprogramming in Pulmonary Arterial Hypertension
National Institutes of Health
Grant: 1S10OD018015-01
XFe96 Analyzer
FWCI
0.49
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals